POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATION

The Lancet

Volumn 333, Issue 8631, 1989, Pages 188-191

  Colston, KayW ^a   Berger, Uta ^a   Coombes, R Charles ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; CALCITRIOL; VITAMIN RECEPTOR;

ANIMAL MODEL; BREAST CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RAT; TISSUE CULTURE;

ADULT; AGED; AGED, 80 AND OVER; ANIMAL; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL DIVISION; FEMALE; HUMAN; HYDROXYCHOLECALCIFEROLS; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RATS; RECEPTORS, CALCITRIOL; RECEPTORS, STEROID; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TUMOR CELLS, CULTURED; VITAMIN D;

EID: 0024575257     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(89)91204-X     Document Type: Article

References (22)

1. Chemotherapy for advanced disease
2. Endocrine treatment of breast cancer: current concepts and future approaches
3. Current status of estrogen and progesterone receptors m breast cancer
4. Immunocytochemical detection of 1,25 dihydroxyvitamin D3 receptor in breast cancer
5. 3 and malignant melanoma; the presence of receptors and inhibition of cell growth in culture
6. 3
7. 3 on cultured osteogenic sarcoma cells: connection with the 1,25-dihydroxyvitamin D3 receptor
8. 3
9. Breast cancer and bone: presence of 1,25-dihydroxyvitamin D receptors in bone metastases from patients with primary carcinoma of the breast
10. 1,25-dihydroxyvitamin D, binding in estrogen-responsive rat breast tumor
11. 1,25 dihydroxyvitamin D3 receptor in human epithelial cancer cell lines
12. 3 inhibition of breast cancer cell proliferation
13. 3 metabolites inhibit human cancer cell growth
14. 3 inhibits the clonogenic growth of transformed cells via its receptor
15. N-methyl-N-nitrosourea-induced rat mammary tumours. Hormonal responsiveness but lack of spontaneous metastasis
16. Response of nitrosomethylurea-induced rat mammary tumour of endocrine therapy and comparison with clinical response
17. 3 prolong survival time of mice inoculated with myeloid leukemia cells
18. 3 in the rat
19. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1a25-dihydroxy-cholecalciferol
20. 1,25-dihydroxyvitamin D-induced differentiation in a human promyelocytylic leukemia cellline (HL60) receptor mediated maturation to macrophage-like cells
21. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo
22. 3 with an oxygen atom in the side chain skeleton: A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcaemia